PfizerAstellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49 percent Reduction In Death Risk Vs. Chemo
| JENYX Fund | USD 55.68 0.68 1.21% |
Slightly above 61% of The Jensen's investor base is looking to short. The analysis of overall sentiment of trading The Jensen Portfolio mutual fund suggests that many investors are alarmed at this time. The Jensen's investing sentiment can be driven by a variety of factors including economic data, The Jensen's earnings reports, geopolitical events, and overall market trends.
The |
Pfizer and Astellas Padcev-Keytruda combo showed durable survival benefits in urothelial cancer, with a higher response rate and no new safety concerns.
Read at benzinga.com
 |
The Jensen Fundamental Analysis
We analyze The Jensen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of The Jensen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Jensen based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Jensen Portfolio is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Jensen Portfolio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with The Jensen mutual fund to make a market-neutral strategy. Peer analysis of The Jensen could also be used in its relative valuation, which is a method of valuing The Jensen by comparing valuation metrics with similar companies.
Peers
The Jensen Related Equities
| HDGFX | The Hartford | 0.80 |
| ||
| PDGIX | T Rowe | 0.86 |
| ||
| JENIX | The Jensen | 1.17 |
| ||
| MIGNX | Massachusetts Investors | 1.44 |
| ||
| CIPIX | Champlain Mid | 1.95 |
|
Other Information on Investing in The Mutual Fund
The Jensen financial ratios help investors to determine whether The Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in The with respect to the benefits of owning The Jensen security.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |